SEC Form 4 · accession 0001363763-15-000017
RespireRx Pharmaceuticals Inc. · RSPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James S J Manuso
Officer — President & CEO · Director
Period of report
Aug 18, 2015
Accepted (ET)
Aug 20, 2015 · 8:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000849636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Options (to purchase shares of Common Stock)F1 | $0.0197 | Aug 18, 2015 | A | 5,081,300 | A | — | Aug 18, 2025 | COmmon Stock | 5,081,300 | 5,081,300 | D |
| Common Stock Options (to purchase shares of Common Stock)F1 | $0.0197 | Aug 18, 2015 | A | 80,000,000 | A | — | Aug 18, 2025 | COmmon Stock | 80,000,000 | 80,000,000 | D |
Explanation of responses
- F1These Common Stock Options vest in three installments: 50 percent on August 18, 2015 (the grant date), 25 percent on February 18, 2016, and 25 percent on August 18, 2016.